Pabau Engage inbox

Pabau Engage is here: every patient conversation in one inbox.

Learn more
Book a demo Book a demo
☰
CCSD Code

CCSD code A1250 – Creation of a subcutaneous CSF reservoir


Code Definition

A1250 is the CCSD code for creation of subcutaneous cerebrospinal fluid reservoir. It sits in the Brain section of the CCSD schedule. It is the surgeon's fee for implanting a reservoir, such as an Ommaya, with its ventricular catheter.

A1250 is a creation-only code. Later visits that access the reservoir to aspirate CSF or inject drugs are not billed under A1250.

Group
2 Brain, cranium and other intracranial organs
Category
Brain
Subcategory
A12 Creation of connection from ventricle of brain
Billable
No
Code also known as
Ommaya reservoir insertion, Rickham reservoir implantation, intraventricular reservoir creation, CSF reservoir implant
Save time. Improve accuracy. Get paid faster.
Automate coding with Pabau

Let Pabau's smart automation suggest the right codes, reduce claim denials, and keep your practice compliant—effortlessly.

  • AI-powered code suggestions
  • Real-time compliance checks
  • Faster claims, fewer denials
Why practices choose Pabau
Save hours every week

Automate repetitive tasks and focus on what matters most—your patients.

Improve accuracy

Reduce coding errors and ensure compliance with the latest regulations.

Get paid faster

Clean claims, fewer denials, and faster reimbursements.

Grow with confidence

Powerful insights and reporting to help your practice thrive.

HIPAA compliant SOC 2 certified GDPR-compliant Trusted by 4,000+ clinics worldwide

Key takeaways

Key takeaways

CCSD Code A1250 covers surgical creation of a subcutaneous CSF reservoir, not later aspiration or injection through it.

The Ommaya reservoir is the device most often implanted under A1250, typically for intraventricular chemotherapy or CSF sampling.

All major UK private insurers, including Bupa, AXA Health and Aviva, require pre-authorisation for elective A1250 procedures. Emergency implantation needs retrospective justification instead.

The anaesthetist bills separately under the insurer’s anaesthetic fee schedule, so anaesthesia is never bundled within A1250.

Pabau, the practice management platform we build, supports CCSD code entry on invoices and records the authorisation code on each claim.

CCSD Code A1250: definition and scope

CCSD Code A1250 covers the creation of a subcutaneous cerebrospinal fluid reservoir. The CCSD schedule defines it, and the Clinical Coding & Schedule Development Group (CCSD) maintains that schedule. The code applies when a surgeon implants a reservoir under the scalp and connects it by catheter to the ventricular system or subdural space.

Later aspiration, injection or revision through the reservoir is not A1250. Code and bill those visits according to the CCSD technical guide and the insurer’s own rules.

Coders and billing teams should read A1250 as a creation-only code. Billing it for an outpatient appointment where an implanted reservoir is accessed for chemotherapy or CSF sampling is an unbundling error. It is also a common trigger for claim refusal.

What is a subcutaneous cerebrospinal fluid reservoir?

A subcutaneous cerebrospinal fluid reservoir is a small dome-shaped silicone device implanted beneath the scalp. A catheter connects it to the lateral ventricle or subdural space. Cerebrospinal fluid lines the brain and spinal cord. The reservoir gives clinicians a port into that system through the skin, without repeated lumbar punctures or open neurosurgical access.

The Ommaya reservoir is the most widely used device in this category, though the Rickham and Salmon-Rickham reservoirs are also in clinical use. All three sit under the scalp on the skull. Clinicians can feel them through the skin and reach them by needle through intact skin.

The CCSD descriptor uses the term “subcutaneous cerebrospinal fluid reservoir” for the device class rather than any single manufacturer’s product. So A1250 applies to Ommaya, Rickham and similar devices.

Clinical indications: when is A1250 used?

Surgeons most often perform the procedure covered by CCSD Code A1250 to deliver intraventricular chemotherapy. Patients usually have leptomeningeal carcinomatosis or carcinomatous meningitis, where cancer cells have seeded the leptomeninges and need direct CNS drug delivery. Patients tolerate repeated lumbar puncture poorly over long treatment courses, so the reservoir offers a more reliable route.

Beyond cancer care, clinical indications include:

  • CSF sampling for diagnosis or monitoring of CNS infections (including bacterial meningitis and cryptococcal meningitis)
  • Intrathecal antibiotic or antifungal delivery in refractory CNS infection
  • Access for intrathecal analgesia where spinal routes are unavailable

The indication must appear in the operative note and, where insurers require it, in the pre-authorisation request. A vague indication such as “CNS disease” will not satisfy most private medical insurers’ clinical evidence requirements.

How the procedure is performed

The consultant neurosurgeon carries out the procedure under general anaesthesia in an operating theatre. Each step below falls within A1250, which helps billing teams see what the code covers.

  1. Scalp incision and burr hole creation: the surgeon makes a small incision over the planned reservoir site, usually the right frontal region, and drills a burr hole through the skull.
  2. Catheter placement: the surgeon passes a silicone catheter through the burr hole into the lateral ventricle (or subdural space, depending on indication). CSF return confirms correct positioning.
  3. Reservoir dome placement: the surgeon connects the reservoir dome to the catheter, seats it subcutaneously over the burr hole and anchors it to the skull if needed.
  4. Imaging confirmation: the team confirms catheter tip position intraoperatively or with immediate post-operative CT/MRI.
  5. Wound closure: the surgeon closes the scalp incision in layers. No external hardware remains.

A1250 covers the whole sequence above, while the anaesthetist bills separately. Later use of the reservoir, such as injecting chemotherapy, aspirating CSF or sampling for culture, is not A1250. Code those encounters according to the CCSD technical guide and the insurer’s rules.

What CCSD Code A1250 includes and excludes

Private insurers and their clinical reviewers apply the CCSD technical guide’s bundling rules when assessing A1250 claims. The table below shows what the code covers and what you bill separately.

Component Status under A1250 Notes
Burr hole creation Included Part of the creation procedure, so do not bill a separate burr hole code
Reservoir dome and catheter Included Device components are part of the surgical creation; not billed separately
Intraoperative imaging for catheter confirmation Included Image guidance is part of the procedure. Check insurer rules on standalone radiology billing
General anaesthesia Excluded, bill separately The anaesthetist bills under the insurer’s anaesthetic fee schedule, linked to the surgical procedure’s CCSD code or category
Reservoir aspiration or injection (same day) Not billed separately Aspirating on the day of surgery, even to confirm CSF return, is generally part of the creation procedure
Ventriculoperitoneal shunt insertion Excluded, separate code required If a VP shunt (A1240) is inserted in the same sitting, code each procedure separately
Theatre and facility fees Excluded, hospital bills separately A1250 is the surgeon’s fee code only

Neighbouring CCSD codes and how to distinguish them

Several CCSD codes sit near A1250 in the Brain section of the schedule, and picking the wrong one is a frequent error on CSF-related claims. The CCSD technical guide gives the official definitions. For codes outside this family, see our CCSD reference for coders.

Code Descriptor Use when…
A1250 Creation of subcutaneous cerebrospinal fluid reservoir The surgeon implants the reservoir dome and catheter for the first time
A1240 Creation of ventriculoperitoneal shunt A shunt drains CSF into the peritoneal cavity. It works differently from a subcutaneous access reservoir
A1300 Maintenance of cerebroventricular shunt (including revision) An existing cerebroventricular shunt needs maintenance or revision, not a new creation
A1301 Revision or replacement of cerebroventricular shunt An existing cerebroventricular shunt is revised or replaced. Check the schedule notes to choose between A1300 and A1301
A2080 Ventricular puncture (as sole procedure) The ventricle is punctured as a standalone procedure, with no reservoir implanted

Never use A1250 for a shunt revision or a VP shunt procedure. The clinical descriptions differ clearly, and insurers’ clinical reviewers will spot the mismatch. Bill a VP shunt under A1240 and a standalone ventricular puncture under A2080.

A1250 documentation requirements

A complete operative note is the main supporting document for any A1250 claim. Building it as one of your digital forms reduces the risk of missing details that trigger insurer queries. The note must include:

  • Device name and manufacturer: e.g. “Ommaya reservoir, [manufacturer name]”
  • Surgical approach: burr hole location, laterality (right or left), and scalp incision technique
  • Catheter tip position: confirm it with intraoperative imaging (CT, fluoroscopy or ultrasound) or immediate post-operative imaging. Record the imaging modality and result verbatim
  • Clinical indication: the specific diagnosis driving the procedure (e.g. “leptomeningeal metastases from breast carcinoma requiring intraventricular chemotherapy”)
  • Surgeon name and GMC number: required on all UK private medical invoices
  • Date and site of procedure
  • ICD-10 diagnosis code: code and document the diagnosis. Insurers cross-reference the diagnosis code against the procedure when adjudicating the claim
Pabau form builder showing the medical form template library and a template preview
With Pabau’s form templates, the device name, imaging result and GMC number each get a fixed place in your A1250 operative note.

Insurers may also ask for a pre-operative MDT letter or the oncology consultant’s recommendation, mainly for cancer-related indications. Include it in the claim pack from the start rather than waiting for an information request.

Pro Tip

Draft a standard A1250 operative note template with every mandatory field as a fixed heading. It prevents the three omissions that most often delay payment. Those are a missing device name, absent imaging confirmation and no GMC number on the invoice.

Pre-authorisation requirements from UK private insurers

All major private medical insurers operating in the UK require pre-authorisation for elective neurosurgical procedures, and A1250 is no exception. The requirement applies to insured patients, whether treated in a private hospital or a private-patient unit in an NHS facility.

Teams new to private practice billing should build pre-authorisation checks into their workflow from day one. Retrospective authorisation is not guaranteed and often results in non-payment.

Insurer Pre-auth required (elective)? Key supporting evidence typically required Emergency implantation
Bupa Yes Oncology consultant letter, diagnosis, intended treatment regime Notify Bupa as soon as possible. Retrospective justification required
AXA Health Yes Specialist referral, clinical summary, proposed procedure code Retrospective review. For the emergency pathway, contact AXA directly
Aviva Yes GP or specialist referral, diagnosis code, procedure justification Post-procedure notification; submit clinical notes promptly
Vitality Health Yes Specialist referral and clinical evidence for the cancer indication Notify immediately. Retrospective review is standard
Healix Yes Clinical summary and CCSD code. Unbundling rules apply Case by case. Contact the Healix pre-admissions team

Policies change, so verify current pre-authorisation requirements on each insurer’s provider portal before submission. For a code-level overview of Bupa’s billing rules, see Bupa CCSD procedure codes.

Common claim denial reasons for A1250

A1250 claims fail for a handful of repeat reasons, and a tighter billing workflow prevents most of them.

  • Missing pre-authorisation: the most common cause of outright refusal. No retrospective authorisation means no payment, so log the pre-authorisation reference number before surgery.
  • Incomplete operative notes: insurers query claims when the operative note lacks the device name, catheter tip confirmation or the surgeon’s GMC number. Submit a complete note with the claim to cut query rates sharply.
  • Wrong code applied: using a VP shunt code or a craniotomy code when A1250 is correct, or the reverse. Clinical reviewers cross-check the operative note’s procedure description against the billed code.
  • Same-day unbundling error: billing reservoir aspiration or injection on the same date as the creation. Aspiration on the day of surgery, even to confirm CSF return, is generally part of the creation procedure. Do not bill it separately.
  • Mismatched ICD-10 diagnosis code: the diagnosis on the claim does not match a recognised indication for reservoir creation. For example, a musculoskeletal diagnosis alongside a neurosurgical intervention raises a clinical plausibility flag.
  • Non-covered indication: some insurers limit coverage of reservoir creation to specific oncological indications. If the indication is infection-related, confirm coverage in the policy terms before proceeding.

When a claim is denied, ask the insurer for its written refusal reason. Insurers overturn most denials for documentation gaps on first appeal once you provide the complete operative note. Keep the pre-authorisation reference, the operative note and all insurer correspondence in the patient’s billing record.

Pro Tip

After each A1250 procedure, set a follow-up task to code the later reservoir access visits. Code them according to the CCSD technical guide and each insurer’s rules, never under A1250. Tracking the whole episode prevents errors when different team members code access visits weeks later.

Anaesthesia and facility billing alongside A1250

A1250 is the surgeon’s fee code. It covers the consultant neurosurgeon’s time, skill and intraoperative decision-making. Two other billable components are always present in an A1250 procedure, and you bill both separately, as the diagram below shows.

Five-step diagram of one A1250 reservoir case
Only the neurosurgeon’s creation work goes under A1250, while the anaesthetist, the hospital and later access visits bill on their own terms. Based on the CCSD Technical Guide (October 2025).

Anaesthesia: the anaesthetist bills under the insurer’s anaesthetic fee schedule, which is linked to the surgical procedure’s CCSD code or category. CCSD itself is a surgical procedure schedule with no anaesthesia codes. Anaesthetic fees should never appear on the surgeon’s invoice, and a combined line item triggers manual review.

Facility and theatre fees: the private hospital or independent sector treatment centre bills separately for theatre time, recovery, consumables and any overnight stay. The facility may bill the device itself, such as the Ommaya reservoir, as a prosthesis charge, depending on the insurer’s agreements.

Ask the facility’s billing department whether the device cost sits inside the theatre fee or on a separate line. Double-billing for device costs is a common audit trigger.

How Pabau supports accurate CCSD Code A1250 billing

Each A1250 case runs from pre-authorisation through surgery to a series of outpatient reservoir access visits. Those visits sit outside A1250 and follow each insurer’s own rules. Across several insurers, that leaves neurosurgical practices exposed to code errors and missed authorisations.

In Pabau’s claims software for practices, CCSD codes are entered straight onto the invoice. Your team records the authorisation code on the claim, and the Send button stays disabled until the required details are in. The operative note can sit on the billing record too.

Pabau checkout screen with a completed invoice billed to Bupa
Pabau raises the insurer invoice at checkout, so an A1250 claim to Bupa starts from the same record as the appointment and operative note.

For neurosurgical consultants, Pabau’s practice management software keeps scheduling, patient records, consent and billing on one platform. That cuts the admin work between clinical and administrative teams. The audit trail at each billing step supports PHIN transparency reporting and insurer information requests.

Manage CCSD billing without the admin burden

Pabau lets neurosurgical practices enter CCSD codes on invoices and record authorisation codes on claims, so billing teams spend less time chasing refusals.

Pabau practice management platform for private neurosurgical billing

Conclusion

Treat A1250 as the surgeon’s fee for creating the reservoir and nothing more. Code the anaesthetic fee, the facility charges and every later access visit on their own terms, and the claim holds up under clinical review.

Most refused A1250 claims trace back to a missing pre-authorisation or an incomplete operative note. Put an authorisation check and a standard note template in place before surgery, and far fewer claims come back queried.

Book a demo to see how Pabau keeps CCSD codes, authorisation codes and operative notes together for every neurosurgical claim.

Continue your research

Continue your research

Need a complete reference for Bupa’s CCSD coding rules? Bupa CCSD procedure codes covers Bupa’s CCSD code schedule, fee conventions, and submission requirements.

Looking for a billing platform built for UK private practice? Pabau claims management supports CCSD code entry on invoices and records the authorisation code on each claim.

Coding a ventriculoperitoneal shunt instead? CCSD Code A1240 covers creation of a VP shunt, with its own indications and documentation.

Puncturing the ventricle without implanting a reservoir? CCSD Code A2080 covers ventricular puncture as a sole procedure.

Comparing billing systems for a UK private practice? Best medical billing software in the UK compares the main options for insurer billing.

Frequently asked questions

What does CCSD Code A1250 cover?

CCSD Code A1250 covers the surgical creation of a subcutaneous cerebrospinal fluid reservoir. That includes the burr hole, catheter placement into the ventricular or subdural space, and implantation of the reservoir dome. Later aspiration, injection or revision through the reservoir is not A1250. Code those visits according to the CCSD technical guide and the insurer’s rules.

Is A1250 used for Ommaya reservoir insertion?

Yes. The Ommaya reservoir is the most commonly implanted subcutaneous CSF reservoir, and A1250 applies when one is surgically created. The code covers the device class rather than one manufacturer’s product, so it also applies to Rickham and Salmon-Rickham reservoirs.

Does A1250 include subsequent reservoir aspiration?

No. Reservoir access visits for aspiration or injection are not billed under A1250. Code and bill them according to the CCSD technical guide and the insurer’s rules. Billing A1250 for an outpatient access visit is an incorrect code selection and a common denial trigger.

Which private insurers require pre-authorisation for A1250?

All major UK private medical insurers, including Bupa, AXA Health, Aviva, Vitality and Healix, require pre-authorisation for elective A1250 procedures. Policies differ in the clinical evidence required and in how emergency cases are handled. Always verify current requirements on each insurer’s provider portal before scheduling the procedure.

Can A1250 be billed alongside a craniotomy code?

Only when the craniotomy is a separate procedure, performed in the same session for a different clinical purpose. Where reservoir creation is the only procedure, use A1250 alone. If a medically necessary craniotomy is also performed, check the CCSD technical guide’s rules on concurrent procedures. Ask the insurer before you submit both codes.

×